Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;1(2):18.
doi: 10.3978/j.issn.2305-5839.2013.06.02.

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA

Catherine Alix-Panabières  1 , Klaus Pantel  1
Affiliations

Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA

Catherine Alix-Panabières et al. Ann Transl Med. 2013 Jul.

Abstract

Liquid biopsy is a new diagnostic concept, i.e., analysis of therapeutic targets and drug resistance-conferring gene mutations on circulating tumor cells and cell-free circulating tumor DNA released into the peripheral blood from metastatic deposits. Here, we discuss current challenges and future perspectives of the liquid biopsy concept in clinical oncology. We postulate that this concept will contribute to a better understanding and clinical management of drug resistance in cancer patients.

Keywords: Cancer; biomarkers; blood; circulating tumor DNA (ctDNA); circulating tumor cells (CTCs); therapy.

PubMed Disclaimer

References

    1. Alix-Panabières C, Pantel K.Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013;59:110-8. - PubMed
    1. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92. - PMC - PubMed
    1. Dawson SJ, Tsui DW, Murtaza M, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013;368:1199-209. - PubMed
    1. Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013;339:580-4. - PMC - PubMed
    1. Schwarzenbach H, Alix-Panabières C, Müller I, et al. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 2009;15:1032-8. - PubMed